Near-infrared light-triggered drug release from a multiple lipid carrier complex using an all-in-one strategy

Journal of Controlled Release

Volumn 261, Issue , 2017, Pages 126-137

  Li, Huipeng ^a   Yang, Xue ^a   Zhou, Zhanwei ^a   Wang, Kaikai ^a   Li, Chenzi ^a   Qiao, Hongzhi ^c   Oupicky, David ^a,b   Sun, Minjie ^a  

^a CHINA PHARMACEUTICAL UNIVERSITY   (China)

^b UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^c NANJING UNIVERSITY OF CHINESE MEDICINE   (China)

Author keywords

AMD3100; Anti metastatic; IR780; IR780 AMD Lip NLCs; Near infrared light triggered drug release; Photothermal antitumor

Indexed keywords

CELL MEMBRANES; HYDROPHILICITY; HYDROPHOBICITY; INFRARED DEVICES; IRRADIATION; LIPOSOMES; PATHOLOGY; PHOSPHOLIPIDS; TUMORS;

AMD3100; ANTI-METASTATIC; ANTI-TUMORS; IR780; IR780-AMD-LIP-NLCS; TRIGGERED DRUG RELEASE;

DRUG PRODUCTS;

ANTINEOPLASTIC AGENT; CHEMOKINE RECEPTOR CXCR4; IR 780; LIPID; LIPOSOME; NANOCARRIER; PLERIXAFOR; UNCLASSIFIED DRUG; 2-(2-(2-CHLORO-3-((1,3-DIHYDRO-3,3-DIMETHYL-1-PROPYL-2H-INDOL-2-YLIDENE)ETHYLIDENE)-1-CYCLOHEXEN-1-YL)ETHENYL)-3,3-DIMETHYL-1-PROPYLINDOLIUM; DRUG CARRIER; HETEROCYCLIC COMPOUND; INDOLE DERIVATIVE; NANOMATERIAL;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; AREA UNDER THE CURVE; ARTICLE; BREAST CANCER; CELL SURFACE; CELL VIABILITY; CONTROLLED DRUG RELEASE; CONTROLLED STUDY; DRUG CYTOTOXICITY; DRUG RECEPTOR BINDING; FEMALE; IN VITRO STUDY; IN VIVO STUDY; IRRADIATION; LASER; LIPOSOMAL DELIVERY; MAXIMUM PLASMA CONCENTRATION; METASTASIS INHIBITION; MOUSE; NANOENCAPSULATION; NONHUMAN; PARTICLE SIZE; PHOSPHOLIPID BILAYER; PRIORITY JOURNAL; TUMOR CELL; ZETA POTENTIAL; ANIMAL; BAGG ALBINO MOUSE; BREAST TUMOR; CHEMICAL PHENOMENA; CHEMISTRY; DRUG DELIVERY SYSTEM; DRUG RELEASE; INFRARED RADIATION; METASTASIS; PATHOLOGY;

ANIMALS; BREAST NEOPLASMS; DRUG CARRIERS; DRUG DELIVERY SYSTEMS; DRUG LIBERATION; FEMALE; HETEROCYCLIC COMPOUNDS; HYDROPHOBIC AND HYDROPHILIC INTERACTIONS; INDOLES; INFRARED RAYS; LIPIDS; LIPOSOMES; MICE; MICE, INBRED BALB C; NANOSTRUCTURES; NEOPLASM METASTASIS;

EID: 85021680663     PISSN: 01683659     EISSN: 18734995     Source Type: Journal    
DOI: 10.1016/j.jconrel.2017.06.029     Document Type: Article

References (50)

1. Rijn, M.V.D., Molecular Portraits of Human Breast Tumours. 2009.
2. Al-Hajj, M., Clarke, M.F., Prospective identification of tumorigenic breast cancer cells. Proc. Natl. Acad. Sci. 100 (2003), 3983–3988.
3. Clarke, M., Collins, R., Derby, S., Davies, D., Evans, E., Godwin, J., Gray, R., Mcgale, P., Peto, R., Wang, Y., Early Breast Cancer Trialists' Collaborative Group. Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and survival and 15-year survival: an overview of the randomised trials. Lancet, 2005.
4. Joyce, J.A., Pollard, J.W., Microenvironmental regulation of metastasis. Nat. Rev. Cancer 9 (2009), 239–252.
5. Valastyan, S., Weinberg, R., Tumor metastasis: molecular insights and evolving paradigms. Cell 147 (2011), 275–292.
6. Wood, S.L., Pernemalm, M., Crosbie, P.A., Whetton, A.D., The role of the tumor-microenvironment in lung cancer-metastasis and its relationship to potential therapeutic targets. Cancer Treat. Rev. 40 (2014), 558–566.
7. Chaffer, C.L., Weinberg, R.A., A perspective on cancer cell metastasis. Science 331 (2011), 1559–1564.
8. Müller, A., Homey, B., Soto, H., Ge, N., Catron, D., Buchanan, M.E., Mcclanahan, T., Murphy, E., Yuan, W., Wagner, S.N., Involvement of chemokine receptors in breast cancer metastasis. Nature 410 (2001), 50–56.
9. Balkwill, F., Cancer and the chemokine network. Nat. Rev. Cancer 4 (2004), 540–550.
10. Wu, B., Chien, E.Y., Mol, C.D., Fenalti, G., Liu, W., Katritch, V., Abagyan, R., Brooun, A., Wells, P., Bi, F.C., Structures of the CXCR4 chemokine GPCR with small-molecule and cyclic peptide antagonists. Science 330 (2010), 1066–1071.
11. Sun, X., Cheng, G., Hao, M., Zheng, J., Zhou, X., Jian, Z., Taichman, R.S., Pienta, K.J., Wang, J., CXCL12/CXCR4/CXCR7 chemokine axis and cancer progression. Cancer & Metastasis Rev. 29 (2010), 709–722.
12. Ling, M., Liu, Y., Zhang, Q., Gao, H., Zhang, Z., Qin, H., Enhanced antitumor and anti-metastasis efficiency via combined treatment with CXCR4 antagonist and liposomal doxorubicin. J. Control. Release 196 (2014), 324–331.
13. Jacobson, O., Weiss, I.D., Szajek, L., Farber, J.M., Kiesewetter, D.O., Cu-64-AMD3100-A novel imaging agent for targeting chemokine receptor CXCR4. Bioorg. Med. Chem. 17 (2009), 1486–1493.
14. Smith, M.C., Luker, K.E., Garbow, J.R., Prior, J.L., Jackson, E., Piwnicaworms, D., Luker, G.D., CXCR4 regulates growth of both primary and metastatic breast cancer. Cancer Res. 64 (2004), 8604–8612.
15. Hatse, S., Princen, K., Bridger, G., Clercq, E.D., Schols, D., Chemokine receptor inhibition by AMD3100 is strictly confined to CXCR4. FEBS Lett. 527 (2002), 255–262.
16. Cheng, L., Yang, K., Li, Y., Chen, J., Wang, C., Shao, M., Lee, S.T., Liu, Z., Facile preparation of multifunctional upconversion nanoprobes for multimodal imaging and dual-targeted photothermal therapy. Angew. Chem. 50 (2011), 7385–7390.
17. Yuan, A., Wu, J., Tang, X., Zhao, L., Xu, F., Hu, Y., Application of near-infrared dyes for tumor imaging, photothermal, and photodynamic therapies. J. Pharm. Sci. 102 (2013), 6–28.
18. Wang, Y., Black, K.C.L., Luehmann, H., Li, W., Zhang, Y., Cai, X., Wan, D., Liu, S.Y., Li, M., Kim, P., Comparison study of gold nanohexapods, nanorods, and nanocages for photothermal cancer treatment. ACS Nano 7 (2013), 2068–2077.
19. Jiang, C., Hao, C., Yuan, A., Tang, X., Wu, J., Hu, Y., Hydrophobic IR780 encapsulated in biodegradable human serum albumin nanoparticles for photothermal and photodynamic therapy. Acta Biomater. 14 (2015), 61–69.
20. Yuan, A., Qiu, X., Tang, X., Liu, W., Wu, J., Hu, Y., Self-assembled PEG-IR-780-C13 micelle as a targeting, safe and highly-effective photothermal agent for invivo imaging and cancer therapy. Biomaterials 51 (2015), 184–193.
21. Guha, S., Shaw, S.K., Spence, G.T., Roland, F.M., Smith, B.D., Clean photothermal heating and controlled release from near-infrared dye doped nanoparticles without oxygen photosensitization. Langmuir the Acs Journal of Surfaces & Colloids 31 (2015), 7826–7834.
22. Chen, G., Wang, K., Zhou, Y., Ding, L., Ullah, A., Hu, Q., Sun, M., Oupický, D., Oral nanostructured lipid carriers loaded with near-infrared dye for image-guided photothermal therapy. ACS Appl. Mater. Interfaces, 2016.
23. Peer, D., Karp, J.M., Hong, S., Farokhzad, O.C., Margalit, R., Langer, R., Nanocarriers as an emerging platform for cancer therapy. Nat. Nanotechnol. 2 (2007), 751–760.
24. Davis, M.E., Zhuo, C., Dong, M.S., Nanoparticle therapeutics: an emerging treatment modality for cancer. Nat. Rev. Drug Discov. 7 (2008), 771–782.
25. Allen, T.M., Cullis, P.R., Drug delivery systems: entering the mainstream. Science 303 (2004), 1818–1822.
26. Das, S., Ng, W.K., Tan, R.B.H., Are nanostructured lipid carriers (NLCs) better than solid lipid nanoparticles (SLNs): development, characterizations and comparative evaluations of clotrimazole-loaded SLNs and NLCs?. European Journal of Pharmaceutical Sciences Official Journal of the European Federation for Pharmaceutical Sciences 47 (2012), 139–151.
27. Fang, C.L., Al-Suwayeh, S.A., Fang, J.Y., Nanostructured lipid carriers (NLCs) for drug delivery and targeting. Recent Patents on Nanotechnology 7 (2013), 41–55.
28. Li, H., Chen, M., Su, Z., Sun, M., Ping, Q., Size-exclusive effect of nanostructured lipid carriers on oral drug delivery. Int. J. Pharm. 511 (2016), 524–537.
29. Gabizon, A., Papahadjopoulos, D., Liposome formulations with prolonged circulation time in blood and enhanced uptake by tumors. Proc. Natl. Acad. Sci. 85 (1988), 6949–6953.
30. Barenholz, Y., Liposome application: problems and prospects. Curr. Opin. Colloid Interface Sci. 6 (2001), 66–77.
31. Gao, D.Y., Lin, T.T., Sung, Y.C., Liu, Y.C., Chiang, W.H., Chang, C.C., Liu, J.Y., Chen, Y., CXCR4-targeted lipid-coated PLGA nanoparticles deliver sorafenib and overcome acquired drug resistance in liver cancer. Biomaterials 67 (2015), 194–203.
32. Gallo, J., Kamaly, N., Lavdas, I., Stevens, E., Nguyen, Q.D., Wylezinska-Arridge, M., Aboagye, E.O., Long, N.J., CXCR4-targeted and MMP-responsive iron oxide nanoparticles for enhanced magnetic resonance imaging †. Angew. Chem. 53 (2014), 9704–9708.
33. Guan, G., Lu, Y., Zhu, X., Liu, L., Chen, J., Ma, Q., Zhang, Y., Wen, Y., Yang, L., Liu, T., CXCR4-targeted near-infrared imaging allows detection of orthotopic and metastatic human osteosarcoma in a mouse model. Sci Rep, 5, 2015.
34. Ganta, S., Devalapally, H., Shahiwala, A., Amiji, M., A review of stimuli-responsive nanocarriers for drug and gene delivery. Journal of Controlled Release Official Journal of the Controlled Release Society 126 (2008), 187–204.
35. Mura, S., Nicolas, J., Couvreur, P., Stimuli-responsive nanocarriers for drug delivery. Nat. Mater. 12 (2013), 991–1003.
36. Ohya, Y., Okuyama, Y., Fukunaga, A., Ouchi, T., Photo-sensitive lipid membrane perturbation by a single chain lipid having terminal spiropyran group. Supramol. Sci. 5 (1998), 21–29.
37. Wang, J.Y., Wu, Q.F., Li, J.P., Ren, Q.S., Wang, Y.L., Liu, X.M., Photo-sensitive liposomes: chemistry and application in drug delivery. Mini Reviews in Medicinal Chemistry 10 (2010), 172–181.
38. Volodkin, D.V., Skirtach, A.G., Möhwald, H., Near-IR remote release from assemblies of liposomes and nanoparticles. Angew. Chem. Int. Ed. 48 (2009), 1807–1809.
39. Fang, G., Meng, Y., Wang, J., Tan, F., Nan, L., Smart IR780 theranostic nanocarrier for tumor-specific therapy: hyperthermia-mediated bubble-generating and folate-targeted liposomes. ACS Appl. Mater. Interfaces, 7, 2015.
40. Seo, H.J., Cha, H.J., Kim, T.S., Kim, J.C., Photo-responsive liposomes decorated with hydrophobically modified poly(vinyl alcohol)–coumarin conjugate. Journal of Industrial & Engineering Chemistry 19 (2013), 310–315.
41. Hribar, K.C., Lee, M.H., Lee, D., Burdick, J.A., Enhanced release of small molecules from near-infrared light responsive polymer − nanorod composites. ACS Nano 5 (2011), 2948–2956.
42. Qin, Y., Chen, J., Ying, B., Xu, X., Hui, Z., Gao, J., Yi, H., Zhao, Y., Chai, Z., Near-infrared light remote-controlled intracellular anti-cancer drug delivery using thermo/pH sensitive nanovehicle. Acta Biomater. 17 (2015), 201–209.
43. Sun, X., Wang, C., Gao, M., Hu, A., Liu, Z., Drug delivery: remotely controlled red blood cell carriers for cancer targeting and near-infrared light-triggered drug release in combined photothermal–chemotherapy. Adv. Funct. Mater. 25 (2015), 2386–2394.
44. Yu, Z., Zeng, L., Wu, A., Yu, Z., Zeng, L., Wu, A., Near-infrared light responsive upconversion nanoparticles for imaging, drug delivery and therapy of cancers. Curr. Nanosci., 11, 2015, 1.
45. Shi, Y., Su, Z., Li, S., Chen, Y., Chen, X., Xiao, Y., Sun, M., Ping, Q., Zong, L., Multistep targeted nano drug delivery system aiming at leukemic stem cells and minimal residual disease. Mol. Pharm. 10 (2013), 2479–2489.
46. Yang, X., Li, L., Wang, Y., Tan, Y., Preparation, pharmacokinetics and tissue distribution of micelles made of reverse thermo-responsive polymers. Int. J. Pharm. 370 (2009), 210–215.
47. Li, J., Zhu, Y., Hazeldine, S.T., Li, C., Oupický, D., Dual-function CXCR4 antagonist polyplexes to deliver gene therapy and inhibit cancer cell invasion. Angew. Chem. Int. Ed. 51 (2012), 8740–8743.
48. Andar, A.U., Hood, R.R., Vreeland, W.N., Devoe, D.L., Swaan, P.W., Microfluidic preparation of liposomes to determine particle size influence on cellular uptake mechanisms. Pharm. Res-Dordr. 31 (2014), 401–413.
49. Kibria, G., Hatakeyama, H., Ohga, N., Hida, K., Harashima, H., The effect of liposomal size on the targeted delivery of doxorubicin to Integrin alpha v beta 3-expressing tumor endothelial cells. Biomaterials 34 (2013), 5617–5627.
50. Takara, K., Hatakeyama, H., Kibria, G., Ohga, N., Hida, K., Harashima, H., Size-controlled, dual-ligand modified liposomes that target the tumor vasculature show promise for use in drug-resistant cancer therapy. J. Control. Release 162 (2012), 225–232.